ArticleMedicine2017
Sarcomatoid carcinoma of the common bile duct: A case report.
Article in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.
- Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.BMC cancer · 2019Pooled it
- Sarcomatoid carcinoma of the common bile duct: A case report and review of the literature.International cancer conference journal · 2026Article
- Concomitant occurrence of primary gastric sarcomatoid carcinoma and giant gastrointestinal stromal tumor: a case report and literature review.Frontiers in oncology · 2026Article
- Case Report: Carcinosarcoma of the common bile duct: a rare case report with literature review.Frontiers in oncology · 2025Article
- A case of spindle and giant cell-type undifferentiated carcinoma of the extrahepatic bile duct.Clinical journal of gastroenterology · 2024Review
- Sarcomatoid carcinoma of the common bile duct presenting as painless jaundice.BMJ case reports · 2023Article
- First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2.World journal of gastroenterology · 2023Article
- Article
- Aggressive behavior of anaplastic undifferentiated carcinoma arising from the hilar bile duct.Surgical case reports · 2022Article
- Experience of the pancreas duodenectomy for so-called carcinosarcoma of the common bile duct:a case report and review of literature.International cancer conference journal · 2021Article
- Observational
- Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development.Scientific reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleSarcomatoid carcinoma is an extremely rare lesion in the common bile duct (CBD). PATIENT CONCERNS: We present a case of sarcomatoid carcinoma of the distal CBD in a 51-year-old woman who presented with jaundice and abdominal pain. Whipple's operation was performed successfully. Microscopically, the tumor was a poorly differentiated carcinoma containing a component of sarcoma-like differentiation. The tumor cells displayed spindle-shaped nuclei with occasional mitotic figures. Cytokeratin (CK) 7, CK19, CK18, and pan-CK (AE1/AE3) staining was positive on immunohistochemistry. Vimentin and carcinoembryonic antigen (CEA) staining were also positive. DIAGNOSES: Sarcomatoid carcinoma of the distal CBD.
interventionsThe patient received three cycles of chemotherapy after surgery. OUTCOMES: The patient has experienced no adverse events in the 3 years post-surgery. LESSONS: We present here a case report of sarcomatoid carcinoma of the distal CBD. The patient received chemotherapy after surgery, and was event-free for 3 years post-surgery, suggesting a relatively better prognosis, despite the infiltrative pattern of the tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.